国家: 台湾
语言: 中文
来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
apalutamide;;apalutamide
嬌生股份有限公司 台北市中山區民生東路三段2號10樓及11樓 (30814854)
L02BB05
膜衣錠
apalutamide (6808400500) MG; apalutamide (6808400500) MG
塑膠瓶裝(HDPE)
製 劑
須由醫師處方使用
JANSSEN ORTHO LLC STATE ROAD 933 KM 0.1 MAMEY WARD, GURABO, PUERTO RICO, 00778 PR
apalutamide
ERLEADA適用於治療下列病人:(1) 轉移性的去勢敏感性前列腺癌 (mCSPC)。(2) 非轉移性的去勢抗性前列腺癌 (nmCRPC)。
有效日期: 2029/03/15; 英文品名: Erleada Film-Coated Tablets 60mg
2019-03-15
® 60 ERLEADA ® FILM-COATED TABLETS 60MG 027596 1 ERLEADA ® • (mCSPC) • (nmCRPC) 2 2.1 ERLEADA ® 240(460)ERLEADA ® (GnRH) 2.2 3 1 (180120) 2.3 ERLEADA 1. ERLEADA4(120) 2. 15 3. 15() 4. 5. 2(60 mL)2(60 mL) ERLEADA [(12.3)] 3 (60)AR 60 4 5 5.1 ERLEADA ® 3 4 ERLEADA ® nmCRPC(SPARTAN)ERLEADA ® 4%3% mCSPC (TITAN) ERLEADA ® 4% 2%SPARTAN TITAN5 (0.5%)ERLEADA ® 2 (0.2%) SPARTANERLEADA4.7%0.8% [ (6.1)] TITAN ERLEADA1.9%2.1%SPARTAN TITAN3(0.2%)ERLEADA2(0.2%) 6 SPARTAN TITAN 5.2 ERLEADA ® (bone-targeted agents) (SPARTAN)ERLEADA ® 12% 7%ERLEADA ® 3%1%3-4 ERLEADA ® (median time) 314 (20 953 )SPARTAN (TITAN)ERLEADA ® 9% 6%3-4(2%)ERLEADA ® 56 (2111)TITAN 5.3 ERLEADA ® [(8.5)] (SPARTAN)ERLEADA ® 16%9% 5.4 ERLEADA ® ERLEADA ® ERLEADA ® ERLEADA ® (SPARTAN TITAN)ERLEADA ® 5 (0.4%)1 (0.1%) ERLEADA ® 159 650 ERLEADA ® 5.5 - ERLEADA ® ERLEADA ® [ (12.1)] ERLEADA ® 3 [(8.18.3)] 6 • [(5.1)] • [(5.2)] • [(5.3)] • [(5.4)] 6.1 (TITAN SPARTAN)(≥10%)ERLEADA ® ( ≥2%) (mCSPC) TITANmCSPC(1:1)ERLEADA ® (240) TITAN(GnRH) ERLEADA ® 20( 0 34) 18( 0.134) ERLEADA ® 10 (2%)(n=3)(n=2) (n=1) (n=1) (n=1) (n=1)(n=1) 8% ERLEADA ® (2%)23%ERLEADA ® (>1%) ERLEADA ® 20%20% 1TITANERLEADA ® ≥10%≥2%2 ERLEADA ® ≥15%(>5%) 1TITAN(mCSPC) ERLEADA ® N=524 N=527 / % 3-4 % % 3-4 % a 17 0.4 15 0.9 b 28 6 9 0.6 11 <1 5 <1 23 0 16 0 18 8 16 9 a CTCAE3 b (rash papular) (rash erythematous)(papule) 2%10%ERLEADA ® (9%6%)(3% 2%)(3%1%)(4%1%) 2 TITAN≥15%ERLEADA ® ( >5%) (mCSPC) ERLEADA ® N=524 N=527 % 3-4 % % 3-4 % 27 0.4 19 0.6 a 17 3 12 2 a (nmCRPC) SPARTANnmCRPC(2:1) ERLEADA ® (240) SPARTAN(GnRH) ERLEADA ® 33 ( 0.1 75 ) 11(0.137) ERLEADA ® 24 (3%)≥2(7 )(3 ) (2 )(3 )11%ERLEADA ® (3%)33% ERLEADA ® (>1%)ERLEADA ® 25%23%(>2%) ERLEADA ® (3%) (4%) 3SPARTANERLEADA ® 10%(absolute increase in frequency) ≥2%4ERLEADA ® 15%(5%) 3SPARTAN(nmCRPC) ERLEADA ® N=803 N=398 / % 3-4 % % 3-4 % a,b 39 1 28 0.3 b 16 0 8 0 c 25 5 6 0.3 d 12 0.1 9 0 e 11 0 9 0 b 16 2 9 0.8 f 12 3 7 0.8 b 16 1 6 0.3 25 14 20 12 14 0 9 0 20 1 15 阅读完整的文件